X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1132) 1132
Publication (91) 91
Newsletter (35) 35
Book Review (15) 15
Book Chapter (4) 4
Conference Proceeding (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
flecainide (735) 735
humans (526) 526
animals (461) 461
male (427) 427
pharmacology & pharmacy (413) 413
flecainide - pharmacology (386) 386
anti-arrhythmia agents - pharmacology (358) 358
female (327) 327
cardiac & cardiovascular systems (264) 264
index medicus (200) 200
anti-arrhythmia agents - therapeutic use (177) 177
electrocardiography (168) 168
electrophysiology (166) 166
adult (162) 162
middle aged (162) 162
dogs (146) 146
flecainide - therapeutic use (131) 131
dose-response relationship, drug (128) 128
heart conduction system - drug effects (128) 128
aged (127) 127
action potentials - drug effects (122) 122
antiarrhythmic drugs (114) 114
arrhythmias, cardiac - drug therapy (112) 112
in vitro techniques (109) 109
heart rate - drug effects (105) 105
heart - drug effects (104) 104
atrial fibrillation (102) 102
arrhythmia (98) 98
anti-arrhythmia agents - adverse effects (92) 92
atrial fibrillation - drug therapy (92) 92
quinidine (90) 90
lidocaine - pharmacology (85) 85
time factors (82) 82
flecainide - administration & dosage (79) 79
flecainide - blood (79) 79
arrhythmias (77) 77
kinetics (77) 77
piperidines - pharmacology (77) 77
propafenone (76) 76
rats (75) 75
drugs (73) 73
quinidine - pharmacology (73) 73
flecainide - pharmacokinetics (71) 71
amiodarone (70) 70
heart (69) 69
encainide (68) 68
flecainide acetate (68) 68
guinea pigs (68) 68
anti-arrhythmia agents - administration & dosage (65) 65
electrocardiography - drug effects (65) 65
flecainide - adverse effects (65) 65
arrhythmias, cardiac - physiopathology (63) 63
sodium channels - drug effects (63) 63
fibrillation (61) 61
heart - physiology (61) 61
lidocaine (61) 61
rabbits (61) 61
disopyramide (59) 59
atrial fibrillation - physiopathology (58) 58
pharmacokinetics (56) 56
peripheral vascular disease (55) 55
pharmacology (55) 55
conduction (54) 54
medicine & public health (54) 54
disopyramide - pharmacology (53) 53
arrhythmias, cardiac - chemically induced (52) 52
sinus rhythm (52) 52
electric stimulation (51) 51
toxicology (51) 51
analysis (50) 50
disease models, animal (50) 50
mechanisms (50) 50
pharmacology/toxicology (50) 50
therapy (50) 50
drug interactions (49) 49
hemodynamics - drug effects (49) 49
risk factors (49) 49
tachycardia (49) 49
anti-arrhythmia agents - pharmacokinetics (48) 48
lidocaine - analogs & derivatives (48) 48
physiology (48) 48
propafenone - pharmacology (48) 48
efficacy (47) 47
patch-clamp techniques (47) 47
administration, oral (46) 46
membrane potentials - drug effects (46) 46
cardiovascular system (45) 45
mexiletine (45) 45
research (45) 45
sodium channel blockers - pharmacology (45) 45
cardiac arrhythmia (43) 43
cardiac pacing, artificial (43) 43
mice (43) 43
mutation (43) 43
blood pressure - drug effects (42) 42
heart atria - drug effects (42) 42
mexiletine - pharmacology (42) 42
drug therapy (40) 40
heart conduction system - physiopathology (40) 40
treatment outcome (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1127) 1127
French (14) 14
Japanese (12) 12
Spanish (5) 5
Chinese (4) 4
German (4) 4
Italian (3) 3
Polish (2) 2
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 01/2013, Volume 344, Issue 1, pp. 23 - 32
Journal Article
Journal Article
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 04/2011, Volume 4, Issue 2, pp. 128 - 135
BACKGROUND—Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac ryanodine receptor (RyR2) or calsequestrin... 
RyR2 | Tetrodotoxin | Quinidine | Procainamide | Catecholaminergic polymorphic ventricular tachycardia | Disopyramide | Class I antiarrhythmic drugs | Flecainide | Lidocaine | Propafenone | Mexiletine | Ranolazine | ARRHYTHMIAS | CALSEQUESTRIN | CARDIAC & CARDIOVASCULAR SYSTEMS | quinidine | SUDDEN-DEATH | FOLLOW-UP | flecainide | LUMINAL CA2 | SARCOPLASMIC-RETICULUM | lidocaine | procainamide | disopyramide | catecholaminergic polymorphic ventricular tachycardia | propafenone | RYANODINE RECEPTOR | LOCAL-ANESTHETICS | ranolazine | tetrodotoxin | class I antiarrhythmic drugs | mexiletine | TRANSGENIC MICE | Lidocaine - pharmacology | Anti-Arrhythmia Agents - pharmacology | Humans | Male | Ryanodine Receptor Calcium Release Channel - metabolism | Calsequestrin - genetics | Mutation, Missense | Dose-Response Relationship, Drug | Young Adult | Time Factors | Defibrillators, Implantable | Procainamide - pharmacology | Tachycardia, Ventricular - metabolism | Electrocardiography | Tachycardia, Ventricular - genetics | Disease Models, Animal | Calsequestrin - deficiency | Propafenone - pharmacology | Tachycardia, Ventricular - drug therapy | Sodium Channel Blockers - pharmacology | Flecainide - pharmacology | Ryanodine Receptor Calcium Release Channel - drug effects | Calcium Channel Blockers - pharmacology | Mice, Knockout | Tachycardia, Ventricular - physiopathology | Animals | Myocytes, Cardiac - drug effects | Analysis of Variance | Electric Countershock - instrumentation | Ryanodine Receptor Calcium Release Channel - genetics | Myocytes, Cardiac - metabolism | Mice | Ion Channel Gating - drug effects
Journal Article
Journal Article
Journal Article
Journal Article